BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:HL-1186 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of HL-1186\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07758920-8800@assetmemo.bio
DTSTAMP:20261121T005907Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:HL-1186: Phase 2 readout est. (NCT07758920)
DESCRIPTION:HL-1186\, phase 2.\nStudy: A Clinical Trial to Evaluate the Eff
 icacy and Safety of HL-1186 Tablet in the Treatment of Postherpetic Neural
 gia\nEstimated primary completion: June 2027. This is a ClinicalTrials.gov
  estimate\, not a confirmed readout date\, and it can move.\nDrug page: ht
 tps://assetmemo.bio/drug/hl-1186#upcoming-events\nRegistry record: https:/
 /clinicaltrials.gov/study/NCT07758920
URL:https://assetmemo.bio/drug/hl-1186#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
